Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of …

DE Kandzari, M Böhm, F Mahfoud, RR Townsend… - The Lancet, 2018 - thelancet.com
Background Previous catheter-based renal denervation studies have reported variable
efficacy results. We aimed to evaluate safety and blood pressure response after renal …

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised …

RR Townsend, F Mahfoud, DE Kandzari, K Kario… - The Lancet, 2017 - thelancet.com
Background Previous randomised renal denervation studies did not show consistent efficacy
in reducing blood pressure. The objective of our study was to evaluate the effect of renal …

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

F Mahfoud, DE Kandzari, K Kario, RR Townsend… - The Lancet, 2022 - thelancet.com
Background Renal denervation has been shown to lower blood pressure in the presence of
antihypertensive medications; however, long-term safety and efficacy data from randomised …

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham …

M Böhm, K Kario, DE Kandzari, F Mahfoud, MA Weber… - The Lancet, 2020 - thelancet.com
Background Catheter-based renal denervation has significantly reduced blood pressure in
previous studies. Following a positive pilot trial, the SPYRAL HTN-OFF MED (SPYRAL …

Renal denervation for hypertension: a systematic review and meta-analysis of randomized, blinded, placebo-controlled trials

Y Ahmad, DP Francis, DL Bhatt, JP Howard - Cardiovascular Interventions, 2021 - jacc.org
Objectives The authors performed an updated meta-analysis of randomized placebo-
controlled trials of renal denervation and specifically compared the effect of renal …

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

DL Bhatt, M Vaduganathan, DE Kandzari, MB Leon… - The Lancet, 2022 - thelancet.com
Summary Background The SYMPLICITY HTN-3 (Renal Denervation in Patients With
Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system …

Adherence to antihypertensive treatment and the blood pressure–lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial

M Azizi, H Pereira, I Hamdidouche, P Gosse… - Circulation, 2016 - Am Heart Assoc
Background: The DENERHTN trial (Renal Denervation for Hypertension) confirmed the
blood pressure–lowering efficacy of renal denervation added to a standardized stepped …

Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials

Y Ogoyama, K Tada, M Abe, S Nanto, H Shibata… - Hypertension …, 2022 - nature.com
The efficacy of renal denervation has been controversial, but recent randomized sham-
controlled trials demonstrated significant blood pressure reductions after renal denervation …

Safety and efficacy of renal denervation in patients taking antihypertensive medications

DE Kandzari, RR Townsend, K Kario, F Mahfoud… - Journal of the American …, 2023 - jacc.org
Background Renal denervation (RDN) reduces blood pressure (BP) in patients with
uncontrolled hypertension in the absence of antihypertensive medications. Objectives This …

Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical …

MD Esler, M Böhm, H Sievert, CL Rump… - European heart …, 2014 - academic.oup.com
Aim The aim of this study was to determine long-term results of renal artery denervation for
treatment of treatment-resistant hypertension in the SYMPLICITY HTN-2 study. Methods …